NCT01872884

Brief Summary

The purpose of this study is to evaluate whether general anesthesia or sedation technique is preferable during embolectomy for stroke, measured in terms of three months neurological impairment. In addition we study if there is any difference between the methods regarding complication frequency.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 7, 2013

Completed
5 months until next milestone

Study Start

First participant enrolled

November 14, 2013

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2016

Completed
Last Updated

October 11, 2017

Status Verified

October 1, 2017

Enrollment Period

2.9 years

First QC Date

June 4, 2013

Last Update Submit

October 10, 2017

Conditions

Keywords

StrokeIschemic strokeAcute strokeEmbolectomyEndovascular therapyIntra-arterial therapySedationAnesthesia

Outcome Measures

Primary Outcomes (1)

  • Neurological outcome in the two different arms

    Neurological outcome is measured as modified Rankin Scale (mRS), 90d post stroke.

    90 days

Secondary Outcomes (7)

  • NIHSS(National Institutes of Health Stroke Scale)

    Day 3,7,90

  • The degree of recanalization and reperfusion

    1 day (After completed embolectomy)

  • Periprocedural complications

    Perioperatively

  • Infarction magnitude

    Day 1 to Day 90

  • Quantitative EEG changes

    Day 1,2,90

  • +2 more secondary outcomes

Study Arms (2)

General anaesthesia

EXPERIMENTAL

General anaesthesia with mechanical ventilation. Sevorane Remifentanil. Bloodpressure control, systolic pressure 140-180 mmHg.

Drug: Sevorane Remifentanil

Sedation

PLACEBO COMPARATOR

Sedation with spontaneous breathing. Remifentanil. Bloodpressure control, systolic pressure 140-180 mmHg

Drug: Remifentanil

Interventions

Sevorane Remifentanil

Also known as: tracheal intubation
General anaesthesia

Remifentanil

Also known as: Conscious sedation
Sedation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • the patient is ≥ 18 years
  • the patient has a CT angio verified embolization \* and / or a NIHSS scores \*\* ≥ 10 (R) or 14 (L) depending on the side engagement
  • embolectomy (= groin puncture) started \<8 hours after symptom onset
  • Embolus in one of the following arteries: internal carotid artery, anterior cerebral (A1 segment), cerebri media (M1 segment) and proximal cerebri media branches (M2 segment).
  • NIHSS (National Institutes of Health Stroke Scale). Patients with embolus in left hemisphere circulation require ≥ 14 points, while patients with embolus in the right hemisphere circulation require ≥ 10 points. This is because occlusion on the right side does not usually cause aphasia, a symptom that usually leads to higher total score of NIHSS.

You may not qualify if:

  • the patient must receive general anesthesia, for medical reasons, according to the responsible anesthesiologist
  • the patient cannot receive general anesthesia, for medical reasons, according to the responsible anesthesiologist
  • the patient has an embolization of posterior brain vessels
  • CT-confirmed intracerebral hemorrhage
  • spontaneous recanalization or spontaneous neurological improvement
  • any other reason that does not allow embolectomy (co-morbidities)
  • premorbid MRS ≥ 4

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sahlgrenska University Hospital

Gothenburg, S-413 45 Göteborg, Sweden

Location

Related Publications (6)

  • Jumaa MA, Zhang F, Ruiz-Ares G, Gelzinis T, Malik AM, Aleu A, Oakley JI, Jankowitz B, Lin R, Reddy V, Zaidi SF, Hammer MD, Wechsler LR, Horowitz M, Jovin TG. Comparison of safety and clinical and radiographic outcomes in endovascular acute stroke therapy for proximal middle cerebral artery occlusion with intubation and general anesthesia versus the nonintubated state. Stroke. 2010 Jun;41(6):1180-4. doi: 10.1161/STROKEAHA.109.574194. Epub 2010 Apr 29.

    PMID: 20431082BACKGROUND
  • Nichols C, Carrozzella J, Yeatts S, Tomsick T, Broderick J, Khatri P. Is periprocedural sedation during acute stroke therapy associated with poorer functional outcomes? J Neurointerv Surg. 2010 Mar;2(1):67-70. doi: 10.1136/jnis.2009.001768. Epub 2009 Dec 17.

    PMID: 20431708BACKGROUND
  • Abou-Chebl A, Lin R, Hussain MS, Jovin TG, Levy EI, Liebeskind DS, Yoo AJ, Hsu DP, Rymer MM, Tayal AH, Zaidat OO, Natarajan SK, Nogueira RG, Nanda A, Tian M, Hao Q, Kalia JS, Nguyen TN, Chen M, Gupta R. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke. 2010 Jun;41(6):1175-9. doi: 10.1161/STROKEAHA.109.574129. Epub 2010 Apr 15.

    PMID: 20395617BACKGROUND
  • Davis MJ, Menon BK, Baghirzada LB, Campos-Herrera CR, Goyal M, Hill MD, Archer DP; Calgary Stroke Program. Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology. 2012 Feb;116(2):396-405. doi: 10.1097/ALN.0b013e318242a5d2.

    PMID: 22222475BACKGROUND
  • Tosello R, Riera R, Tosello G, Clezar CN, Amorim JE, Vasconcelos V, Joao BB, Flumignan RL. Type of anaesthesia for acute ischaemic stroke endovascular treatment. Cochrane Database Syst Rev. 2022 Jul 20;7(7):CD013690. doi: 10.1002/14651858.CD013690.pub2.

  • Lowhagen Henden P, Rentzos A, Karlsson JE, Rosengren L, Leiram B, Sundeman H, Dunker D, Schnabel K, Wikholm G, Hellstrom M, Ricksten SE. General Anesthesia Versus Conscious Sedation for Endovascular Treatment of Acute Ischemic Stroke: The AnStroke Trial (Anesthesia During Stroke). Stroke. 2017 Jun;48(6):1601-1607. doi: 10.1161/STROKEAHA.117.016554.

MeSH Terms

Conditions

Ischemic StrokeStroke

Interventions

Intubation, IntratrachealRemifentanilConscious Sedation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Airway ManagementTherapeuticsIntubationInvestigative TechniquesPropionatesAcids, AcyclicCarboxylic AcidsOrganic ChemicalsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsAnesthesia and Analgesia

Study Officials

  • Alexandros Rentzos, MD

    Diagnostic and interventional Neuroradiology, Radiology department, Sahlgrenska Academy, University of Gothenburg

    PRINCIPAL INVESTIGATOR
  • Pia Löwhagen Henden, MD

    Anesthesiology, Sahlgrenska Academy, University of Gothenburg

    PRINCIPAL INVESTIGATOR
  • Sven-Erik Ricksten, MD PhD Prof

    Sahlgrenska Academy, University of Gothenburg

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

June 4, 2013

First Posted

June 7, 2013

Study Start

November 14, 2013

Primary Completion

September 30, 2016

Study Completion

September 30, 2016

Last Updated

October 11, 2017

Record last verified: 2017-10

Locations